POINT RICHMOND, Calif., March 9 /PRNewswire-FirstCall/ -- Transcept Pharmaceuticals, Inc. , a specialty pharmaceutical company focused on the development and commercialization of proprietary products that address important therapeutic needs in the field of neuroscience, today announced that it plans to release fourth quarter and full year 2009 financial results on March 23, 2010 after the close of the market. At 5:00 p.m. Eastern Time, Transcept management will host a webcast and teleconference to discuss these results.
A simultaneous webcast of the conference call will be available on the Investors section of the Transcept website at www.transcept.com. A replay of this webcast will be available on the website beginning shortly after the conclusion of the call through April 23, 2010.
About Transcept
CONTACT: Greg Mann, Director, Corporate Communications of Transcept
Pharmaceuticals, Inc., +1-510-215-3567, gmann@transcept.com
Web site: http://www.transcept.com/
